Portopulmonary Hypertension Treated by Occlusion of a Spontaneous Portosystemic Shunt Followed by Endothelin Receptor Antagonist Administration

被引：1
|
作者：
Ishikawa, Tsuyoshi [1 ]
Kawamoto, Daiki [1 ]
Nishimura, Tatsuro [1 ]
Suetomi, Takeshi [2 ]
Kobayashi, Shigeki [3 ]
Takami, Taro [1 ]
机构：
[1] Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan
[2] Yamaguchi Univ, Grad Sch Med, Dept Med & Clin Sci, Ube, Yamaguchi, Japan
[3] Yamaguchi Univ, Sch Med, Dept Therapeut Sci Heart Failure Elderly, Ube, Yamaguchi, Japan
来源：
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY | 2024年 / 35卷 / 02期
关键词：
D O I：
10.1016/j.jvir.2023.10.028
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：313 / 315
页数：3
相关论文
共 50 条
  • [1] Endothelin-Receptor Antagonist Treatment of Portopulmonary Hypertension
    Hinterhuber, Lukas
    Graziadei, Ivo W.
    Kaehler, Christian M.
    Jaschke, Werner
    Vogel, Wolfgang
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2004, 2 (11) : 1039 - 1042
  • [2] Successful treatment of portopulmonary hypertension with the selective endothelin receptor antagonist Sitaxentan
    Kaehler, Christian M.
    Graziadei, Ivo
    Vogelsinger, Helene
    Desole, Susanna
    Cima, Katharina
    Vogel, Wolfgang
    WIENER KLINISCHE WOCHENSCHRIFT, 2011, 123 (7-8) : 248 - 252
  • [3] Endothelin and endothelin receptor antagonism in portopulmonary hypertension
    Neuhofer, W.
    Guelberg, V.
    Gerbes, A. L.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 : 54 - 61
  • [4] Use of oral endothelin-receptor antagonist bosentan in the treatment of portopulmonary hypertension
    Halank, M
    Miehlke, S
    Hoeffken, G
    Schmeisser, A
    Schulze, M
    Strasser, RH
    TRANSPLANTATION, 2004, 77 (11) : 1775 - 1776
  • [5] SPONTANEOUS PORTOSYSTEMIC SHUNTS AS A THERAPEUTIC TARGET FOR PORTOPULMONARY HYPERTENSION
    Ishikawa, Tsuyoshi
    Nishiyama, Natsuko
    Egusa, Maho
    Fujioka, Tsuyoshi
    Kawamoto, Daiki
    Sasaki, Ryo
    Nishimura, Tatsuro
    Tanabe, Norikazu
    Saeki, Issei
    Takami, Taro
    HEPATOLOGY, 2023, 78 : S1412 - S1413
  • [6] Use of a mixed endothelin receptor antagonist in portopulmonary hypertension:: A safe and effective therapy?
    Kuntzen, C
    Gülberg, V
    Gerbes, AL
    GASTROENTEROLOGY, 2005, 128 (01) : 164 - 168
  • [7] A Case Report of Portopulmonary Hypertension Precipitated by Transjugular Intrahepatic Portosystemic Shunt
    Tatah, Jasmine H.
    Weir, E. Kenneth
    Prins, Kurt W.
    Thenappan, Thenappan
    CHEST, 2021, 159 (04) : E193 - E196
  • [8] Unusual rapid development of portopulmonary hypertension after shunt closure for congenital portosystemic shunt
    Honda, Shohei
    Kawakita, Issei
    Okumura, Kazuyoshi
    Ara, Momoko
    Goto, Ryoichi
    Takeda, Atsuhito
    Shimamura, Tsuyoshi
    Kawahara, Insu
    Taketomi, Akinobu
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2024, 60 (10) : 606 - 609
  • [9] Transcatheter Portosystemic Shunt Occlusion in Patients with Portal Hypertension
    Jajodia, Surabhi
    Khandelwal, A. H.
    Khandelwal, R.
    Kapoor, A. K.
    Baijal, S. S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 59 - 59
  • [10] Prevalence of Spontaneous Portosystemic Shunts in Patients With Portopulmonary Hypertension and Effect on Treatment
    Talwalkar, Jayant A.
    Swanson, Karen L.
    Krowka, Michael J.
    Andrews, James C.
    Kamath, Patrick S.
    GASTROENTEROLOGY, 2011, 141 (05) : 1673 - 1679
12345